Lozada, Keeran Aziel S.
HRN: 24-14-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/08/2024
01/14/2024
IVT
33mg
OD
Pcap Severe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes